If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEntain Regulatory News (ENT)

Share Price Information for Entain (ENT)

Share Price is delayed by 15 minutes
Get Live Data
521.00    -7.60 (-1.44%)
Bid:
520.60
Ask:
521.20
Spread: 0.60 (0.115%)
Market Cap: £3.33b
ENT Live PriceLast checked at - London Stock Exchange

Intraday Entain Share Chart

Offer Talks Terminated

26 Oct 2021 12:46

RNS Number : 3123Q
DraftKings Inc.
26 October 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

THIS ANNOUNCEMENT IS AN ANNOUNCEMENT FALLING UNDER RULE 2.8 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE").

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION.

FOR IMMEDIATE RELEASE

26 October 2021

 

DraftKings Inc. ("DraftKings")

 

Statement regarding Entain plc ("Entain")

 

DraftKings (NASDAQ: DKNG) confirms that, following further analysis and discussions with the Entain board of directors, it will not make a firm offer for Entain.

Commenting on this, Jason Robins DraftKings CEO, Co-Founder and Chairman of the Board said:

"After several discussions with Entain leadership, DraftKings has decided that it will not make a firm offer for Entain at this time. Based on our vertically-integrated technology stack, best-in-class product and technology capabilities and leading brand, we are highly confident in our ability to maintain a leadership position and achieve our long-term growth plans in the rapidly growing North America market."

As a result of this announcement, DraftKings is bound by the restrictions under Rule 2.8 of the Code for six months following the date of this announcement.

For the purpose of Rule 2.8 of the Code, DraftKings reserves the right to set aside the above statement and the restrictions in Rule 2.8 of the Code in the following circumstances:

(i) with the agreement of the board of directors of Entain;

(ii) following the announcement of a firm intention to make an offer for Entain by or on behalf of a third party;

(iii) following the announcement by Entain of a "whitewash" proposal (as described in Note 1 of the Notes on Dispensations from Rule 9 of the Code) or a reverse takeover (as defined in the Code); or

(iv) where the Takeover Panel has determined that there has been a material change of circumstances.

 

Enquiries

 

Press:

Joe DeCristofaro, Investor Relations

Media@draftkings.com

+1 617 986 6744

 

 

The Raine Group, financial adviser to DraftKings

 

+44 20 3695 8600

 

John Salter

Colin Neville

Jason Schretter

Brett Varsov

Garrett Gomes

 

 

 

Credit Suisse, financial adviser to DraftKings

 

+44 20 7888 8888

 

Michael Kamras

Joe Hannon

Ben Deary

Matt Hall (Corporate Broking)

 

 

 

 

 

Important Notices

This announcement is not intended to, and does not, constitute or form part of any offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities or the solicitation of any vote in any jurisdiction whether pursuant to this announcement or otherwise, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

The release, publication or distribution of this announcement in whole or in part, directly or indirectly, in, into or from certain jurisdictions outside the United Kingdom may be restricted by law and therefore persons into whose possession this announcement comes should inform themselves about, and observe, such restrictions. Any failure to comply with the restrictions may constitute a violation of the securities law of any such jurisdiction.

Financial Advisers

Raine Advisors Limited ("Raine"), which is an Appointed Representative of Sapia Partners LLP, an entity which is authorised and regulated in the United Kingdom by the Financial Conduct Authority (FRN: 550103), is acting as financial adviser exclusively for DraftKings and no one else in connection with the matters set out in this announcement and will not be responsible to any person other than DraftKings for providing the protections afforded to clients of Raine, nor for providing advice in relation to the content of this announcement or any matter referred to herein. Neither Raine nor any of its affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Raine in connection with this announcement, any statement contained herein or otherwise.

 

Credit Suisse International ("Credit Suisse"), which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority in the UK, is acting as financial adviser exclusively for DraftKings and no one else in connection with the matters set out in this announcement and will not be responsible to any person other than DraftKings for providing the protections afforded to clients of Credit Suisse, nor for providing advice in relation to the content of this announcement or any matter referred to herein. Neither Credit Suisse nor any of its subsidiaries, branches or affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Credit Suisse in connection with this announcement, any statement contained herein or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
OTTDZMZGMVFGMZM
Date   Source Headline
2nd Feb 20267:00 amRNSTotal Voting Rights
23rd Jan 20264:21 pmRNSTR1: Notification of Major Holdings
19th Jan 20261:42 pmRNSTR1: Notification of Major Holdings
5th Jan 20263:39 pmRNSDirector/PDMR Shareholding
23rd Dec 20253:52 pmRNSTR1: Notification of Major Holdings
23rd Dec 20253:52 pmRNSTR1: Notification of Major Holdings
11th Dec 20257:00 amRNSGroup Chief Financial Officer succession
4th Dec 20258:42 amRNSTR1: Notification of Major Holdings
3rd Dec 20251:00 pmRNSDirector/PDMR Shareholding
1st Dec 20257:00 amRNSTotal Voting Rights
26th Nov 20255:46 pmRNSStatement re increases to UK gambling taxes
20th Nov 20257:00 amRNSTR1: Notification of Major Holdings
13th Nov 20257:00 amRNSPricing of €500 million Senior Secured Notes
10th Nov 20258:00 amRNSProposed Refinancing Transaction
6th Nov 20253:10 pmRNSDirector/PDMR Shareholding
3rd Nov 202510:00 amRNSTotal Voting Rights
15th Oct 20257:00 amRNSQ3 Trading Update
14th Oct 202512:00 pmRNSBetMGM Q3 2025 Update and Raised FY25 Guidance
14th Oct 20258:59 amRNSTR1: Notification of Major Holdings
1st Oct 20257:01 amRNSBlock Listing Six Monthly Return
1st Oct 20257:00 amRNSTotal Voting Rights
5th Sep 20252:44 pmRNSDirector/PDMR Shareholding
1st Sep 20257:00 amRNSTotal Voting Rights
12th Aug 20257:01 amRNSInterim Results
12th Aug 20257:00 amRNSAppointment of Non-Executive Chair
1st Aug 20257:00 amRNSTotal Voting Rights
31st Jul 20257:00 amRNSSuccessful repricing and extension of Term Loans
29th Jul 20257:00 amRNSBETMGM 2Q/1H 2025 UPDATE & FY25 GUIDANCE INCREASE
3rd Jul 20252:00 pmRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSTotal Voting Rights
30th Jun 20259:00 amRNS-RNew Zealand Government Establishes Legislative Net
16th Jun 20257:00 amRNSBetMGM - Upgraded FY 2025 Guidance
4th Jun 20259:48 amRNSDirector/PDMR Shareholding
2nd Jun 202510:26 amRNSTotal Voting Rights
15th May 20257:00 amRNSBoard Appointments
6th May 202512:34 pmRNSDirector/PDMR Shareholding
1st May 20257:00 amRNSTotal Voting Rights
29th Apr 20257:01 amRNSQ1 Trading Update
29th Apr 20257:00 amRNSAppointment of Chief Executive Officer
28th Apr 202512:00 pmRNSBetMGM Q1 2025 Update
23rd Apr 202511:59 amRNSResult of AGM
4th Apr 202510:20 amRNSTR1: Notification of Major Holdings
3rd Apr 20259:35 amRNSDirector/PDMR Shareholding
1st Apr 20257:01 amRNSBlock Listing Six Monthly Return
1st Apr 20257:00 amRNSTotal Voting Rights
21st Mar 20254:33 pmRNSAnnual Report, AGM and Directorate Change
19th Mar 202510:39 amRNSDirector/PDMR Shareholding
17th Mar 20259:46 amRNSTR1: Notification of Major Holdings
10th Mar 20252:24 pmRNSDirector/PDMR Shareholding
6th Mar 20257:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.